312 related articles for article (PubMed ID: 9754754)
1. Therapeutic node dissections in malignant melanoma.
Karakousis CP
Ann Surg Oncol; 1998 Sep; 5(6):473-82. PubMed ID: 9754754
[TBL] [Abstract][Full Text] [Related]
2. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic node dissections in malignant melanoma.
Karakousis CP
Semin Surg Oncol; 1998 Jun; 14(4):291-301. PubMed ID: 9588722
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant irradiation for axillary metastases from malignant melanoma.
Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites?
Wevers KP; Bastiaannet E; Poos HP; van Ginkel RJ; Plukker JT; Hoekstra HJ
Ann Surg Oncol; 2012 Nov; 19(12):3913-8. PubMed ID: 22588472
[TBL] [Abstract][Full Text] [Related]
7. Standardized axillary lymphadenectomy improves local control but not survival in patients with palpable lymph node metastases of cutaneous malignant melanoma.
Kretschmer L; Preusser KP
Langenbecks Arch Surg; 2001 Nov; 386(6):418-25. PubMed ID: 11735014
[TBL] [Abstract][Full Text] [Related]
8. The results of node resection for clinically enlarged lymph nodes in malignant melanoma.
Rayner CR
Br J Plast Surg; 1981 Apr; 34(2):152-6. PubMed ID: 7236972
[TBL] [Abstract][Full Text] [Related]
9. Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma.
Gershenwald JE; Berman RS; Porter G; Mansfield PF; Lee JE; Ross MI
Ann Surg Oncol; 2000 Apr; 7(3):226-31. PubMed ID: 10791854
[TBL] [Abstract][Full Text] [Related]
10. The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma.
Vucetić B; Andreja Rogan S; Balenović A; Ivkić M; Situm M; Hudorović N; Kusić Z
Wien Klin Wochenschr; 2006 May; 118(9-10):286-93. PubMed ID: 16810487
[TBL] [Abstract][Full Text] [Related]
11. Complete lymph node dissection for regional nodal metastasis.
Dzwierzynski WW
Clin Plast Surg; 2010 Jan; 37(1):113-25. PubMed ID: 19914463
[TBL] [Abstract][Full Text] [Related]
12. Controversies in the management of metastatic melanoma to regional lymphatic basins.
Mack LA; McKinnon JG
J Surg Oncol; 2004 Jul; 86(4):189-99. PubMed ID: 15221926
[TBL] [Abstract][Full Text] [Related]
13. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
14. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
[TBL] [Abstract][Full Text] [Related]
15. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of additional positive lymph nodes in complete lymphadenectomy specimens after positive sentinel lymphadenectomy findings for early-stage melanoma of the head and neck.
Pu LL; Wells KE; Cruse CW; Shons AR; Reintgen DS
Plast Reconstr Surg; 2003 Jul; 112(1):43-9. PubMed ID: 12832875
[TBL] [Abstract][Full Text] [Related]
17. Outcomes following therapeutic lymphadenectomy for Stage III malignant melanoma in a single unit.
Jayakar R; Yassaie E; Adams C
N Z Med J; 2018 May; 131(1474):51-59. PubMed ID: 29723179
[TBL] [Abstract][Full Text] [Related]
18. In regard to: Lee RJ, et al. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J. Radiat oncol biol phys 2000;46:467-474.
Kretschmer L; Neumann C; Marsch WC
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1267-8. PubMed ID: 11072188
[No Abstract] [Full Text] [Related]
19. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
[TBL] [Abstract][Full Text] [Related]
20. Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.
Theodore JE; Frankel AJ; Thomas JM; Barbour AP; Bayley GJ; Allan CP; Wagels M; Smithers BM
ANZ J Surg; 2017 Jan; 87(1-2):44-48. PubMed ID: 27102082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
